Cargando…

Dasatinib induced pleuro-pericardial effusion

Detalles Bibliográficos
Autores principales:	Mishra, Ajay Kumar, Sahu, Kamal Kant, Kaul, Sudesh, Lal, Amos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2020
Materias:	E-Letters: Comments and Responses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569591/ https://www.ncbi.nlm.nih.gov/pubmed/32191670 http://dx.doi.org/10.23750/abm.v91i1.8914

Ejemplares similares

Dasatinib induced pleural effusions - Reply
por: AJ Abdulla, Mohammad, et al.
Publicado: (2020)

Workplace Safety: Both Physical and Emotional
por: Lal, Amos, et al.
Publicado: (2021)

Minoxidil-Induced Pleuro-Pericardial Effusion With Tamponade
por: Akinleye, Akintayo, et al.
Publicado: (2023)

Dasatinib-Induced Pleural and Pericardial Effusions
por: Hailan, Yousef M, et al.
Publicado: (2021)

Anesthetic challenges for pleuro-pericardial window
por: Bansal, Rakhi, et al.
Publicado: (2019)

Metformin, arterial contrast and acute kidney injury
por: Amos, Lal, et al.
Publicado: (2019)

A Collaborative Approach to Treatment Strategies for Latent Tuberculosis Infection
por: Lal, Amos, et al.
Publicado: (2020)

Optic nerve sheath diameter in critically ill patients: nuances and interpretation
por: Lal, Amos, et al.
Publicado: (2020)

Mechanisms of stroke and the role of anticoagulants in COVID-19
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Cardiovascular factors predicting poor outcome in COVID-19 patients
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Calciphylaxis: Challenges in the diagnosis and management
por: Sahu, Kamal Kant, et al.
Publicado: (2019)

Reply to 'The link between pulmonary hypertension and adverse renal transplant outcome may be renal venous hypertension'
por: Solanki, Sohan Lal, et al.
Publicado: (2018)

Imatinib-Induced Pleuro-Pericardial Effusion and Atrial Fibrillation: An Unusual Side Effect Following the Treatment of a Rare Gastrointestinal Tumor
por: Patel, Neel N, et al.
Publicado: (2023)

Vaccination status as a criterion for prioritizing COVID-19 care; ethical or not ethical?
por: Ramphul, Kamleshun, et al.
Publicado: (2022)

Response to Comment on Smith et al. Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation. Diabetes 2015;64:1555–1563
por: Smith, Gordon I., et al.
Publicado: (2015)

Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264–270
por: Rickels, Michael R., et al.
Publicado: (2016)

Response to comments: Quadratus lumborum block failure: ‘A must know complication’
por: Sindwani, Gaurav, et al.
Publicado: (2018)

Reply to: Society of Onco-Anaesthesia and Perioperative Care advisory on anaesthesia in COVID-19: What is lacking?
por: Solanki, Sohan Lal, et al.
Publicado: (2020)

Letter to the Editor Regarding “Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community”
por: Mishra, Ajay Kumar, et al.
Publicado: (2020)

Unilateral giant internal jugular vein – In response
por: Ganesh, Venkata, et al.
Publicado: (2019)

Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
por: Kostev, Karel
Publicado: (2020)

Comment on Löndahl. Number Eight in the Service of Diabetic Foot Ulcer Healing. Diabetes Care 2020;43:515–517
por: Frykberg, Robert G.
Publicado: (2020)

Nasal cytology identifies healthy and damaged nasal epithelial cells - Reply
por: Gelardi, Matteo, et al.
Publicado: (2020)

Ciliated nasal epithelial cells damage and human rhinovirus infection: cytological findings
por: Martínez-Girón, Rafael, et al.
Publicado: (2020)

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306
por: Segar, Matthew W., et al.
Publicado: (2020)

Response to Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912–1920
por: Nauck, Michael A., et al.
Publicado: (2020)

Comment on Miller and Orchard: Understanding Metabolic Memory: A Tale of Two Studies. Diabetes 2020;69:291–299
por: Lachin, John M., et al.
Publicado: (2020)

Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care 2020;43:244–246
por: Brand, Kerstin
Publicado: (2020)

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020)

Response to Comment on Misra et al. Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes. Diabetes Care 2020;43:909–912
por: Misra, Shivani, et al.
Publicado: (2020)

Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392–1398
por: He, Zebao, et al.
Publicado: (2020)

Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38–e39
por: Benhamou, Pierre Yves, et al.
Publicado: (2020)

Comment on Satin et al. “Take Me To Your Leader”: An Electrophysiological Appraisal of the Role of Hub Cells in Pancreatic Islets. Diabetes 2020;69:830–836
por: Rutter, Guy A., et al.
Publicado: (2020)

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
por: So, Michelle, et al.
Publicado: (2020)

Comment on Mäkimattila et al. Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study. Diabetes Care 2020;43:1041–1047
por: Bellastella, Giuseppe, et al.
Publicado: (2020)

Response to Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
por: Mizokami-Stout, Kara R., et al.
Publicado: (2020)

Response to Comment on Satin et al. “Take Me To Your Leader”: An Electrophysiological Appraisal of the Role of Hub Cells in Pancreatic Islets. Diabetes 2020;69:830–836
por: Satin, Leslie S., et al.
Publicado: (2020)

Response to Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
por: Gan, Sushrima, et al.
Publicado: (2020)

Spinal Cord Injury Without Radiological Abnormalities and the importance of Magnetic Resonance: not only diagnostic, but also predictive!
por: Martínez-Pérez, Rafael, et al.
Publicado: (2020)

Comment on Liu et al. Aberrant Expression of FBXO2 Disrupts Glucose Homeostasis Through Ubiquitin-Mediated Degradation of Insulin Receptor in Obese Mice. Diabetes 2017;66:689–698
por: Wong, Siauyen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7an1rouoopi6vmalvnki7l4nno